EDGAR Filing Documents for 0001493152-17-004210

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001493152-17-004210

Filing Date

2017-04-20

Accepted

2017-04-20 08:49:17

Documents

Period of Report

2017-04-17

Document Format Files

Seq	Description	Document	Type	Size
1		form4.html	4
1		form4.xml	4	3921
	Complete submission text file	0001493152-17-004210.txt		5609

Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809

Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384

OncBioMune Pharmaceuticals, Inc (Issuer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCBIOMUNE PHARMACEUTICALS INC., 11441 INDUSTRIPLEX BLVD, SUITE 190 BATON ROUGE LA 70809

Business Address

Type: 4 | Act: 34 | File No.: 000-52218 | Film No.: 17771531